ライム病治療薬の世界市場成長（現状と展望） 2023-2029

Global Lyme Disease Treatment Market Growth (Status and Outlook) 2023-2029

ライム病治療薬の世界市場規模は、2022年の百万米ドルから2029年には百万米ドルになると予測されており、2023年から2029年までの年平均成長率は %と予測されています。ライム病治療薬の米国市場は、2023年から2... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
LP Information LPインフォメーション	2023年3月3日	US$3,660 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	102	英語

目次
図表リスト

サマリー

ライム病治療薬の世界市場規模は、2022年の百万米ドルから2029年には百万米ドルになると予測されており、2023年から2029年までの年平均成長率は %と予測されています。
ライム病治療薬の米国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると予測されています。
ライム病治療薬の中国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年までに百万米ドルに増加すると推定されます。
ライム病治療薬のヨーロッパ市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年までに百万米ドルに増加すると推定されます。
世界の主要なライム病治療薬プレーヤーは、GlaxoSmithKlin、Pfizer、Novartis、Roche、Almirall、、Mayne Pharma、Boehringer Ingelheim、Galderma LaboratoriesおよびLupin Pharmaceuticalsなどをカバーしています。収益面では、世界の2大企業が2022年にほぼ％のシェアを占めています。
LPI（エルピーアイ）の最新調査レポート「ライム病治療薬の業界予測」は、過去の売上高から2022年の世界のライム病治療薬の総売上高を検討し、2023年から2029年のライム病治療薬の売上予測について地域や市場分野ごとに包括的な分析を提供しています。ライム病治療薬の売上を地域別、市場分野別、サブセクター別に分類し、世界のライム病治療薬産業の詳細な分析（百万米ドル単位）を提供します。
本インサイトレポートは、世界のライム病治療の状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要な動向を明らかにしています。また、本レポートでは、ライム病治療のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析し、加速する世界のライム病治療市場におけるこれらの企業の独自のポジションをよりよく理解することができます。
本インサイトレポートでは、ライム病治療の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、本調査予測は、世界のライム病治療の現状と将来の軌道について非常にニュアンスのある見解を提供します。
本レポートでは、ライム病治療薬市場の製品タイプ、用途、主要プレイヤー、主要地域、国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
オーラル
インジェクタブル
トピック
アプリケーション別セグメント
ヒューマンズ
動物
また、本レポートでは、市場を地域別に分類しています。
米州
ユーエスエー
カナダ
メキシコ
ブラジル
APAC
中国
おのごろじま
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
連邦王国
イタリア
ロシア
中近東・アフリカ
エジプト
南ア
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選ばれています。
グラクソ・スミスクリン（GlaxoSmithKlin
ファイザー
ノバルティス
ロシュ
アルミラルです。
メーンファーマ
ベーリンガーインゲルハイム
ガルデルマ・ラボラトリーズ
ルパンファーマシューティカルズ
チャートウェル・ファーマシューティカルズ
サンファーマシューティカル
ペリゴ・カンパニー
株式会社オリオン
アムナルファーマシューティカルズ

ページTOPに戻る

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lyme Disease Treatment Market Size 2018-2029
2.1.2 Lyme Disease Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Lyme Disease Treatment Segment by Type
2.2.1 Oral
2.2.2 Injectable
2.2.3 Topic
2.3 Lyme Disease Treatment Market Size by Type
2.3.1 Lyme Disease Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Lyme Disease Treatment Market Size Market Share by Type (2018-2023)
2.4 Lyme Disease Treatment Segment by Application
2.4.1 Humans
2.4.2 Animals
2.5 Lyme Disease Treatment Market Size by Application
2.5.1 Lyme Disease Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Lyme Disease Treatment Market Size Market Share by Application (2018-2023)
3 Lyme Disease Treatment Market Size by Player
3.1 Lyme Disease Treatment Market Size Market Share by Players
3.1.1 Global Lyme Disease Treatment Revenue by Players (2018-2023)
3.1.2 Global Lyme Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Lyme Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lyme Disease Treatment by Regions
4.1 Lyme Disease Treatment Market Size by Regions (2018-2023)
4.2 Americas Lyme Disease Treatment Market Size Growth (2018-2023)
4.3 APAC Lyme Disease Treatment Market Size Growth (2018-2023)
4.4 Europe Lyme Disease Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Lyme Disease Treatment Market Size Growth (2018-2023)
5 Americas
5.1 Americas Lyme Disease Treatment Market Size by Country (2018-2023)
5.2 Americas Lyme Disease Treatment Market Size by Type (2018-2023)
5.3 Americas Lyme Disease Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lyme Disease Treatment Market Size by Region (2018-2023)
6.2 APAC Lyme Disease Treatment Market Size by Type (2018-2023)
6.3 APAC Lyme Disease Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lyme Disease Treatment by Country (2018-2023)
7.2 Europe Lyme Disease Treatment Market Size by Type (2018-2023)
7.3 Europe Lyme Disease Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lyme Disease Treatment by Region (2018-2023)
8.2 Middle East & Africa Lyme Disease Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Lyme Disease Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lyme Disease Treatment Market Forecast
10.1 Global Lyme Disease Treatment Forecast by Regions (2024-2029)
10.1.1 Global Lyme Disease Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Lyme Disease Treatment Forecast
10.1.3 APAC Lyme Disease Treatment Forecast
10.1.4 Europe Lyme Disease Treatment Forecast
10.1.5 Middle East & Africa Lyme Disease Treatment Forecast
10.2 Americas Lyme Disease Treatment Forecast by Country (2024-2029)
10.2.1 United States Lyme Disease Treatment Market Forecast
10.2.2 Canada Lyme Disease Treatment Market Forecast
10.2.3 Mexico Lyme Disease Treatment Market Forecast
10.2.4 Brazil Lyme Disease Treatment Market Forecast
10.3 APAC Lyme Disease Treatment Forecast by Region (2024-2029)
10.3.1 China Lyme Disease Treatment Market Forecast
10.3.2 Japan Lyme Disease Treatment Market Forecast
10.3.3 Korea Lyme Disease Treatment Market Forecast
10.3.4 Southeast Asia Lyme Disease Treatment Market Forecast
10.3.5 India Lyme Disease Treatment Market Forecast
10.3.6 Australia Lyme Disease Treatment Market Forecast
10.4 Europe Lyme Disease Treatment Forecast by Country (2024-2029)
10.4.1 Germany Lyme Disease Treatment Market Forecast
10.4.2 France Lyme Disease Treatment Market Forecast
10.4.3 UK Lyme Disease Treatment Market Forecast
10.4.4 Italy Lyme Disease Treatment Market Forecast
10.4.5 Russia Lyme Disease Treatment Market Forecast
10.5 Middle East & Africa Lyme Disease Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Lyme Disease Treatment Market Forecast
10.5.2 South Africa Lyme Disease Treatment Market Forecast
10.5.3 Israel Lyme Disease Treatment Market Forecast
10.5.4 Turkey Lyme Disease Treatment Market Forecast
10.5.5 GCC Countries Lyme Disease Treatment Market Forecast
10.6 Global Lyme Disease Treatment Forecast by Type (2024-2029)
10.7 Global Lyme Disease Treatment Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 GlaxoSmithKlin
11.1.1 GlaxoSmithKlin Company Information
11.1.2 GlaxoSmithKlin Lyme Disease Treatment Product Offered
11.1.3 GlaxoSmithKlin Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GlaxoSmithKlin Main Business Overview
11.1.5 GlaxoSmithKlin Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Lyme Disease Treatment Product Offered
11.2.3 Pfizer Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Lyme Disease Treatment Product Offered
11.3.3 Novartis Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Lyme Disease Treatment Product Offered
11.4.3 Roche Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Almirall,
11.5.1 Almirall, Company Information
11.5.2 Almirall, Lyme Disease Treatment Product Offered
11.5.3 Almirall, Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Almirall, Main Business Overview
11.5.5 Almirall, Latest Developments
11.6 Mayne Pharma
11.6.1 Mayne Pharma Company Information
11.6.2 Mayne Pharma Lyme Disease Treatment Product Offered
11.6.3 Mayne Pharma Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Mayne Pharma Main Business Overview
11.6.5 Mayne Pharma Latest Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Information
11.7.2 Boehringer Ingelheim Lyme Disease Treatment Product Offered
11.7.3 Boehringer Ingelheim Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Boehringer Ingelheim Main Business Overview
11.7.5 Boehringer Ingelheim Latest Developments
11.8 Galderma Laboratories
11.8.1 Galderma Laboratories Company Information
11.8.2 Galderma Laboratories Lyme Disease Treatment Product Offered
11.8.3 Galderma Laboratories Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Galderma Laboratories Main Business Overview
11.8.5 Galderma Laboratories Latest Developments
11.9 Lupin Pharmaceuticals
11.9.1 Lupin Pharmaceuticals Company Information
11.9.2 Lupin Pharmaceuticals Lyme Disease Treatment Product Offered
11.9.3 Lupin Pharmaceuticals Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Lupin Pharmaceuticals Main Business Overview
11.9.5 Lupin Pharmaceuticals Latest Developments
11.10 Chartwell Pharmaceuticals
11.10.1 Chartwell Pharmaceuticals Company Information
11.10.2 Chartwell Pharmaceuticals Lyme Disease Treatment Product Offered
11.10.3 Chartwell Pharmaceuticals Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Chartwell Pharmaceuticals Main Business Overview
11.10.5 Chartwell Pharmaceuticals Latest Developments
11.11 Sun Pharmaceutical
11.11.1 Sun Pharmaceutical Company Information
11.11.2 Sun Pharmaceutical Lyme Disease Treatment Product Offered
11.11.3 Sun Pharmaceutical Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Sun Pharmaceutical Main Business Overview
11.11.5 Sun Pharmaceutical Latest Developments
11.12 Perrigo Company
11.12.1 Perrigo Company Company Information
11.12.2 Perrigo Company Lyme Disease Treatment Product Offered
11.12.3 Perrigo Company Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Perrigo Company Main Business Overview
11.12.5 Perrigo Company Latest Developments
11.13 Orion Corporation
11.13.1 Orion Corporation Company Information
11.13.2 Orion Corporation Lyme Disease Treatment Product Offered
11.13.3 Orion Corporation Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Orion Corporation Main Business Overview
11.13.5 Orion Corporation Latest Developments
11.14 Amneal Pharmaceuticals
11.14.1 Amneal Pharmaceuticals Company Information
11.14.2 Amneal Pharmaceuticals Lyme Disease Treatment Product Offered
11.14.3 Amneal Pharmaceuticals Lyme Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Amneal Pharmaceuticals Main Business Overview
11.14.5 Amneal Pharmaceuticals Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Lyme Disease Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injectable
Table 4. Major Players of Topic
Table 5. Lyme Disease Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Lyme Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Lyme Disease Treatment Market Size Market Share by Type (2018-2023)
Table 8. Lyme Disease Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Lyme Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Lyme Disease Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global Lyme Disease Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Lyme Disease Treatment Revenue Market Share by Player (2018-2023)
Table 13. Lyme Disease Treatment Key Players Head office and Products Offered
Table 14. Lyme Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Lyme Disease Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Lyme Disease Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global Lyme Disease Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Lyme Disease Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Lyme Disease Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Lyme Disease Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas Lyme Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Lyme Disease Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas Lyme Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Lyme Disease Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC Lyme Disease Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Lyme Disease Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC Lyme Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Lyme Disease Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC Lyme Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Lyme Disease Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe Lyme Disease Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Lyme Disease Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe Lyme Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Lyme Disease Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe Lyme Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Lyme Disease Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Lyme Disease Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Lyme Disease Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Lyme Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Lyme Disease Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Lyme Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Lyme Disease Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Lyme Disease Treatment
Table 46. Key Market Challenges & Risks of Lyme Disease Treatment
Table 47. Key Industry Trends of Lyme Disease Treatment
Table 48. Global Lyme Disease Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Lyme Disease Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Lyme Disease Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Lyme Disease Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. GlaxoSmithKlin Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 53. GlaxoSmithKlin Lyme Disease Treatment Product Offered
Table 54. GlaxoSmithKlin Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. GlaxoSmithKlin Main Business
Table 56. GlaxoSmithKlin Latest Developments
Table 57. Pfizer Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 58. Pfizer Lyme Disease Treatment Product Offered
Table 59. Pfizer Main Business
Table 60. Pfizer Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Pfizer Latest Developments
Table 62. Novartis Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 63. Novartis Lyme Disease Treatment Product Offered
Table 64. Novartis Main Business
Table 65. Novartis Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Novartis Latest Developments
Table 67. Roche Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 68. Roche Lyme Disease Treatment Product Offered
Table 69. Roche Main Business
Table 70. Roche Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Roche Latest Developments
Table 72. Almirall, Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 73. Almirall, Lyme Disease Treatment Product Offered
Table 74. Almirall, Main Business
Table 75. Almirall, Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Almirall, Latest Developments
Table 77. Mayne Pharma Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 78. Mayne Pharma Lyme Disease Treatment Product Offered
Table 79. Mayne Pharma Main Business
Table 80. Mayne Pharma Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Mayne Pharma Latest Developments
Table 82. Boehringer Ingelheim Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 83. Boehringer Ingelheim Lyme Disease Treatment Product Offered
Table 84. Boehringer Ingelheim Main Business
Table 85. Boehringer Ingelheim Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Boehringer Ingelheim Latest Developments
Table 87. Galderma Laboratories Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 88. Galderma Laboratories Lyme Disease Treatment Product Offered
Table 89. Galderma Laboratories Main Business
Table 90. Galderma Laboratories Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Galderma Laboratories Latest Developments
Table 92. Lupin Pharmaceuticals Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 93. Lupin Pharmaceuticals Lyme Disease Treatment Product Offered
Table 94. Lupin Pharmaceuticals Main Business
Table 95. Lupin Pharmaceuticals Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Lupin Pharmaceuticals Latest Developments
Table 97. Chartwell Pharmaceuticals Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 98. Chartwell Pharmaceuticals Lyme Disease Treatment Product Offered
Table 99. Chartwell Pharmaceuticals Main Business
Table 100. Chartwell Pharmaceuticals Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Chartwell Pharmaceuticals Latest Developments
Table 102. Sun Pharmaceutical Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 103. Sun Pharmaceutical Lyme Disease Treatment Product Offered
Table 104. Sun Pharmaceutical Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Sun Pharmaceutical Main Business
Table 106. Sun Pharmaceutical Latest Developments
Table 107. Perrigo Company Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 108. Perrigo Company Lyme Disease Treatment Product Offered
Table 109. Perrigo Company Main Business
Table 110. Perrigo Company Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Perrigo Company Latest Developments
Table 112. Orion Corporation Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 113. Orion Corporation Lyme Disease Treatment Product Offered
Table 114. Orion Corporation Main Business
Table 115. Orion Corporation Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Orion Corporation Latest Developments
Table 117. Amneal Pharmaceuticals Details, Company Type, Lyme Disease Treatment Area Served and Its Competitors
Table 118. Amneal Pharmaceuticals Lyme Disease Treatment Product Offered
Table 119. Amneal Pharmaceuticals Main Business
Table 120. Amneal Pharmaceuticals Lyme Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Amneal Pharmaceuticals Latest Developments
List of Figures
Figure 1. Lyme Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lyme Disease Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Lyme Disease Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Lyme Disease Treatment Sales Market Share by Country/Region (2022)
Figure 8. Lyme Disease Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Lyme Disease Treatment Market Size Market Share by Type in 2022
Figure 10. Lyme Disease Treatment in Humans
Figure 11. Global Lyme Disease Treatment Market: Humans (2018-2023) & ($ Millions)
Figure 12. Lyme Disease Treatment in Animals
Figure 13. Global Lyme Disease Treatment Market: Animals (2018-2023) & ($ Millions)
Figure 14. Global Lyme Disease Treatment Market Size Market Share by Application in 2022
Figure 15. Global Lyme Disease Treatment Revenue Market Share by Player in 2022
Figure 16. Global Lyme Disease Treatment Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Lyme Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 18. APAC Lyme Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 19. Europe Lyme Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Lyme Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Americas Lyme Disease Treatment Value Market Share by Country in 2022
Figure 22. United States Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Lyme Disease Treatment Market Size Market Share by Region in 2022
Figure 27. APAC Lyme Disease Treatment Market Size Market Share by Type in 2022
Figure 28. APAC Lyme Disease Treatment Market Size Market Share by Application in 2022
Figure 29. China Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Lyme Disease Treatment Market Size Market Share by Country in 2022
Figure 36. Europe Lyme Disease Treatment Market Size Market Share by Type (2018-2023)
Figure 37. Europe Lyme Disease Treatment Market Size Market Share by Application (2018-2023)
Figure 38. Germany Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Lyme Disease Treatment Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Lyme Disease Treatment Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Lyme Disease Treatment Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Lyme Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 52. APAC Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 53. Europe Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 55. United States Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Canada Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 59. China Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Japan Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 61. Korea Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 63. India Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Australia Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 65. Germany Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 66. France Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 67. UK Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 68. Italy Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 69. Russia Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Spain Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Israel Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Lyme Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Global Lyme Disease Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Lyme Disease Treatment Market Size Market Share Forecast by Application (2024-2029)

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

The global Lyme Disease Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Lyme Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Lyme Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Lyme Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Lyme Disease Treatment players cover GlaxoSmithKlin, Pfizer, Novartis, Roche, Almirall,, Mayne Pharma, Boehringer Ingelheim, Galderma Laboratories and Lupin Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Lyme Disease Treatment Industry Forecast” looks at past sales and reviews total world Lyme Disease Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Lyme Disease Treatment sales for 2023 through 2029. With Lyme Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lyme Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Lyme Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lyme Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lyme Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lyme Disease Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lyme Disease Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Lyme Disease Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Oral
Injectable
Topic
Segmentation by application
Humans
Animals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKlin
Pfizer
Novartis
Roche
Almirall,
Mayne Pharma
Boehringer Ingelheim
Galderma Laboratories
Lupin Pharmaceuticals
Chartwell Pharmaceuticals
Sun Pharmaceutical
Perrigo Company
Orion Corporation
Amneal Pharmaceuticals

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

LP Information 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

LP Information社はどのような調査会社ですか?

LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

ライム病治療薬の世界市場成長（現状と展望） 2023-2029

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

LP Information 社の最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

LP Information社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?